News
Clinical Trial Press Release
Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis
Clinical Trial Gouvernance News Press Release
4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients
Clinical Trial Gouvernance News Press Release
4Moving Biotech completes the recruitment of its Phase I Clinical Trial
Clinical Trial News Press Release
4Moving Biotech announces First Patient Enrolled in Phase I clinical trial
Clinical Trial News
4Moving Biotech obtains regulatory authorization to initiate LASARE phase I clinical trial
End of content